agilon health, inc. SEC filings AGL

agilon health, inc. has 432 filings in SEC EDGAR's recent list, going back to Dec 21, 2020. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

agilon health, inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Officer or director change
Jul 22, 2026 Jul 17, 2026
8-K Current report
Shareholder vote results
Jun 3, 2026 Jun 2, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
DEFA14A Additional proxy material Apr 27, 2026 —
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 27, 2026 Apr 24, 2026
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 22, 2026 Jun 2, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Mar 30, 2026 Mar 30, 2026
8-K Current report
Shareholder vote results, Other events
Mar 18, 2026 Mar 17, 2026
10-K Annual report Feb 25, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 25, 2026 Feb 25, 2026
DEFA14A Additional proxy material Feb 20, 2026 —
DEF 14A Proxy statement Feb 18, 2026 Mar 17, 2026
8-K Current report
Material agreement, New debt
Feb 12, 2026 Feb 12, 2026
PRE 14A Preliminary proxy statement Feb 6, 2026 Mar 17, 2026
8-K Current report
Officer or director change
Jan 7, 2026 Dec 31, 2025
8-K Current report
Listing notice, Regulation FD disclosure
Nov 7, 2025 Nov 5, 2025
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 4, 2025 Nov 4, 2025
10-Q Quarterly report Aug 4, 2025 Jun 30, 2025
8-K Current report
Results of operations, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Aug 4, 2025 Jul 29, 2025
8-K Current report
Shareholder vote results
May 30, 2025 May 28, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 6, 2025 May 6, 2025
DEFA14A Additional proxy material May 6, 2025 —
ARS Annual report to shareholders Apr 17, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 17, 2025 —
DEF 14A Proxy statement Apr 17, 2025 May 28, 2025
10-K Annual report Feb 25, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Feb 25, 2025 Feb 25, 2025
8-K Current report
Material agreement, Other events
Dec 5, 2024 Dec 4, 2024
8-K Current report
Regulation FD disclosure
Nov 19, 2024 Nov 19, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 7, 2024 Nov 7, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 5, 2024 Jun 4, 2024
8-K Current report
Shareholder vote results
Jun 3, 2024 May 29, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
ARS Annual report to shareholders Apr 18, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 18, 2024 —
DEF 14A Proxy statement Apr 18, 2024 May 29, 2024
10-K Annual report Feb 27, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Feb 27, 2024 Feb 27, 2024
8-K Current report
Officer or director change
Feb 8, 2024 Feb 8, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 5, 2024 Jan 5, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Jan 5, 2024 Jan 5, 2024
8-K Current report
Regulation FD disclosure
Nov 14, 2023 Nov 14, 2023
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
8-K Current report
Officer or director change
Aug 16, 2023 Aug 11, 2023
10-K/A Amended annual report Aug 8, 2023 Dec 31, 2022
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
8-K Current report
Officer or director change, Other events
Jun 26, 2023 Jun 21, 2023
8-K Current report
Shareholder vote results
May 25, 2023 May 24, 2023
8-K Current report
Other events
May 18, 2023 May 15, 2023
424B7 Form 424(b)(7) May 17, 2023 —
FWP Free writing prospectus May 16, 2023 —
424B7 Form 424(b)(7) May 15, 2023 —
S-3ASR Automatic shelf registration May 15, 2023 —
DEFA14A Additional proxy material May 12, 2023 —
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
UPLOAD Letter from the SEC May 2, 2023 —
CORRESP Letter to the SEC May 1, 2023 —
UPLOAD Letter from the SEC Apr 24, 2023 —
DEFA14A Additional proxy material Apr 14, 2023 —
DEF 14A Proxy statement Apr 14, 2023 —
CORRESP Letter to the SEC Apr 3, 2023 —
UPLOAD Letter from the SEC Mar 21, 2023 —
10-K Annual report Mar 1, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 1, 2023 Mar 1, 2023
8-K Current report
Officer or director change
Feb 22, 2023 Feb 17, 2023
8-K Current report
Regulation FD disclosure
Jan 9, 2023 Jan 9, 2023
8-K Current report
Officer or director change
Dec 20, 2022 Dec 19, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Officer or director change
Sep 30, 2022 Sep 30, 2022
8-K Current report
Officer or director change
Aug 10, 2022 Aug 10, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Shareholder vote results
May 24, 2022 May 24, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
8-K Current report
Officer or director change
Apr 28, 2022 Apr 25, 2022
DEFA14A Additional proxy material Apr 11, 2022 —
DEF 14A Proxy statement Apr 11, 2022 May 24, 2022
10-K Annual report Mar 3, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 3, 2022 Mar 3, 2022
8-K Current report
Officer or director change
Feb 14, 2022 Feb 11, 2022
8-K Current report
Officer or director change
Feb 7, 2022 Feb 4, 2022
8-K Current report
Regulation FD disclosure
Jan 10, 2022 Jan 10, 2022
8-K Current report
Officer or director change
Dec 6, 2021 Dec 2, 2021
10-Q Quarterly report Oct 28, 2021 Sep 30, 2021
8-K Current report
Results of operations
Oct 28, 2021 Oct 28, 2021
424B4 Prospectus Sep 13, 2021 —
EFFECT Filing Sep 9, 2021 —
S-1/A Amended registration statement Sep 7, 2021 —
S-1 Registration statement Aug 30, 2021 —
10-Q Quarterly report Aug 4, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 4, 2021 Aug 4, 2021
DRS Filing Jul 26, 2021 —
8-K Current report
Officer or director change, Other events
Jul 12, 2021 Jul 9, 2021
10-Q Quarterly report May 26, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 26, 2021 May 26, 2021
8-K Current report
Material agreement, Agreement ended, Change to shareholder rights, Bylaw or fiscal year change, Other events
Apr 19, 2021 Apr 14, 2021
424B4 Prospectus Apr 16, 2021 —
EFFECT Filing Apr 14, 2021 —
S-8 Employee stock plan registration Apr 14, 2021 —
CERT Nyse certification Apr 14, 2021 —
8-A12B Form 8-a12b Apr 14, 2021 —
CORRESP Letter to the SEC Apr 12, 2021 —
CORRESP Letter to the SEC Apr 12, 2021 —
S-1/A Amended registration statement Apr 7, 2021 —
CORRESP Letter to the SEC Apr 5, 2021 —
UPLOAD Letter from the SEC Apr 2, 2021 —
CORRESP Letter to the SEC Apr 2, 2021 —
CORRESP Letter to the SEC Mar 18, 2021 —
S-1 Registration statement Mar 18, 2021 —
UPLOAD Letter from the SEC Mar 5, 2021 —
DRSLTR Filing Feb 10, 2021 —
DRS/A Filing Feb 10, 2021 —
UPLOAD Letter from the SEC Jan 18, 2021 —
DRSLTR Filing Dec 21, 2020 —
DRS Filing Dec 21, 2020 —

Showing 133 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as
AGL (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Westerville, OH
SEC filer status
Large accelerated filer
SEC CIK
1831097
Former names
Agilon Health Topco, Inc. (until Feb 10, 2021)

Other Services-Misc Health & Allied Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.